Researchers at the Keck School of Medicine of USC and the Cleveland Clinic Florida Research and Innovation Center have published studies focused on GRP78, a protein implicated in both COVID-19 and multiple types of cancer, and a drug that interferes with its effects.
This column is a love letter of sorts to our field, a recognition of all that we have accomplished and an acknowledgement that we need to find a path forward that supports and empowers the best of what it is to invest in cancer research.
